Feng Su

1.6k total citations
26 papers, 554 citations indexed

About

Feng Su is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Feng Su has authored 26 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 11 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Feng Su's work include Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (8 papers) and Hepatitis C virus research (6 papers). Feng Su is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (8 papers) and Hepatitis C virus research (6 papers). Feng Su collaborates with scholars based in United States, China and Canada. Feng Su's co-authors include George N. Ioannou, Kristin Berry, Andrew M. Moon, Iris Liou, Jorgé Reyes, Charles Landis, Lei Yu, Stephen C. Rayhill, Noel S. Weiss and Lauren A. Beste and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Feng Su

25 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Su United States 15 299 267 142 99 64 26 554
Jen‐Jung Pan United States 15 229 0.8× 332 1.2× 167 1.2× 104 1.1× 63 1.0× 36 584
Yukui Ma China 14 240 0.8× 111 0.4× 316 2.2× 95 1.0× 22 0.3× 59 529
Vincenzo Scuderi Italy 15 514 1.7× 125 0.5× 545 3.8× 67 0.7× 12 0.2× 28 761
Jung‐Min Lee South Korea 11 122 0.4× 206 0.8× 60 0.4× 148 1.5× 38 0.6× 37 526
Amane Kitasato Japan 17 137 0.5× 109 0.4× 555 3.9× 81 0.8× 16 0.3× 77 740
Che-Chuan Loong Taiwan 10 450 1.5× 294 1.1× 217 1.5× 68 0.7× 51 0.8× 14 614
Tomonari Shimagaki Japan 13 170 0.6× 113 0.4× 107 0.8× 112 1.1× 21 0.3× 47 467
Pei‐Chang Lee Taiwan 14 404 1.4× 295 1.1× 151 1.1× 177 1.8× 79 1.2× 60 742
Hüseyin Astarcıoğlu Türkiye 13 68 0.2× 85 0.3× 161 1.1× 96 1.0× 42 0.7× 33 402
Christopher M. Freeman United States 11 98 0.3× 111 0.4× 114 0.8× 295 3.0× 72 1.1× 17 537

Countries citing papers authored by Feng Su

Since Specialization
Citations

This map shows the geographic impact of Feng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Su more than expected).

Fields of papers citing papers by Feng Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Su. The network helps show where Feng Su may publish in the future.

Co-authorship network of co-authors of Feng Su

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Su. A scholar is included among the top collaborators of Feng Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Su. Feng Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Feng & Ira M. Jacobson. (2023). Chronic Hepatitis B. Clinics in Liver Disease. 27(4). 791–808. 4 indexed citations
2.
Li, Xiang, Guangwei He, Feng Su, et al.. (2020). Regorafenib-loaded poly (lactide-co-glycolide) microspheres designed to improve transarterial chemoembolization therapy for hepatocellular carcinoma. Asian Journal of Pharmaceutical Sciences. 15(6). 739–751. 19 indexed citations
3.
Su, Feng, Noel S. Weiss, Lauren A. Beste, et al.. (2020). Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B. Journal of Hepatology. 74(4). 850–859. 17 indexed citations
4.
Benhammou, Jihane N., Andrew M. Moon, Joseph R. Pisegna, et al.. (2020). Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C. Digestive Diseases and Sciences. 66(7). 2394–2406. 24 indexed citations
5.
Vutien, Philip, Nicole J. Kim, Andrew M. Moon, et al.. (2020). Fibroscan liver stiffness after anti‐viral treatment for hepatitis C is independently associated with adverse outcomes. Alimentary Pharmacology & Therapeutics. 52(11-12). 1717–1727. 18 indexed citations
6.
Su, Feng, Kristin Berry, & George N. Ioannou. (2020). No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir. Gut. 70(2). 370–378. 30 indexed citations
7.
Kong, Xuejun, Huamin Wang, Yanling Gao, et al.. (2019). Protective Effect of Compound Cotinus coggygria Oral Liquid on Mice Acute Liver Injury Induced by D-Galactosamine.. PubMed. 49(3). 361–367.
8.
Moon, Andrew M., Noel S. Weiss, Lauren A. Beste, et al.. (2018). No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis. Gastroenterology. 155(4). 1128–1139.e6. 84 indexed citations
9.
Su, Feng, et al.. (2018). Study on acute toxicity of compound coggygria oral liquid. AIP conference proceedings. 1956. 20038–20038. 2 indexed citations
10.
Duan, Peng, Li Yang, Shiqiang Wei, et al.. (2018). Opening of mitoKATP improves cardiac function and inhibits apoptosis via the AKT-Foxo1 signaling pathway in diabetic cardiomyopathy. International Journal of Molecular Medicine. 42(5). 2709–2719. 22 indexed citations
11.
Ng, Chaan S., Zheng Zhang, Susanna I. Lee, et al.. (2017). CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study. Clinical Cancer Research. 23(14). 3684–3691. 20 indexed citations
12.
Wong, Boaz, et al.. (2017). ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice. PLoS ONE. 12(3). e0174315–e0174315. 8 indexed citations
13.
Su, Feng, Wen‐Jun Li, Dakun Zhang, et al.. (2017). Hepatoprotective effect of Fufang-Huanglu oral liquid on α- naphthylisothiocyanate-induced hepatitis jaundice in mice. Tropical Journal of Pharmaceutical Research. 16(2). 343–343. 1 indexed citations
14.
Zhou, Fuyou, Chen Zhao, Zhikun Ma, et al.. (2016). Gastric cardia adenocarcinoma microRNA profiling in Chinese patients. Tumor Biology. 37(7). 9411–9422. 25 indexed citations
15.
Su, Feng, Lei Yu, Kristin Berry, et al.. (2015). Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit. Gastroenterology. 150(2). 441–453.e6. 142 indexed citations
16.
Sun, Yu, Ziyang Huang, Zhenhua Wang, et al.. (2015). TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease. Molecular and Cellular Biochemistry. 406(1-2). 131–138. 17 indexed citations
17.
Su, Feng, Lan Zhao, Shaoheng Zhang, et al.. (2015). Cardioprotection by PI3K-mediated signaling is required for anti-arrhythmia and myocardial repair in response to ischemic preconditioning in infarcted pig hearts. Laboratory Investigation. 95(8). 860–871. 17 indexed citations
18.
Wang, Jiahong, Feng Su, Shijun Wang, et al.. (2014). CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.. PubMed. 7(10). 6514–23. 16 indexed citations
19.
Qiu, Mingning, Chunchun Han, Bo Wu, et al.. (2013). The Influence of Ovarian Stromal/Theca Cells During In Vitro Culture on Steroidogenesis, Proliferation and Apoptosis of Granulosa Cells Derived from the Goat Ovary. Reproduction in Domestic Animals. 49(1). 170–176. 31 indexed citations
20.
He, Xianbao, Feng Su, Yongli Song, et al.. (2011). Ipr1 Gene Mediates RAW 264.7 Macrophage Cell Line Resistance to Mycobacterium bovis. Scandinavian Journal of Immunology. 74(5). 438–444. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jen‐Jung Pan Breakdown of academic impact, for papers by Yukui Ma Breakdown of academic impact, for papers by Vincenzo Scuderi Breakdown of academic impact, for papers by Jung‐Min Lee Breakdown of academic impact, for papers by Amane Kitasato Breakdown of academic impact, for papers by Che-Chuan Loong Breakdown of academic impact, for papers by Tomonari Shimagaki Breakdown of academic impact, for papers by Pei‐Chang Lee Breakdown of academic impact, for papers by Hüseyin Astarcıoğlu Breakdown of academic impact, for papers by Christopher M. Freeman
Rankless by CCL
2026